MCID: RBL001
MIFTS: 56

Rubella malady

Categories: Rare diseases, Infectious diseases, Skin diseases, Fetal diseases, Neuronal diseases

Aliases & Classifications for Rubella

About this section

Summaries for Rubella

About this section
MedlinePlus:37 Rubella is an infection caused by a virus. it is usually mild with fever and a rash. about half of the people who get rubella do not have symptoms. if you do get them, symptoms may include a rash that starts on the face and spreads to the body mild fever aching joints, especially in young women swollen glands rubella is most dangerous for a pregnant woman's baby. it can cause miscarriage or birth defects. rubella spreads when an infected person coughs or sneezes. people without symptoms can still spread it. there is no treatment, but the measles-mumps-rubella (mmr) vaccine can prevent it. centers for disease control and prevention

MalaCards based summary: Rubella, also known as german measles, is related to myelitis and malignant histiocytosis, and has symptoms including rash on the face which spreads to the trunk, fever and lymphadenopathy. An important gene associated with Rubella is CD40LG (CD40 Ligand), and among its related pathways are Antigen Presentation- Folding, assembly and peptide loading of class I MHC and Staphylococcus aureus infection. Affiliated tissues include skin, skin and eye.

Disease Ontology:11 A viral infectious disease that results in infection located in skin, has material basis in Rubella virus, which is transmitted by droplet spread of oronasal secretions from the infected person through coughing and sneezing, and transmitted by congenital method. The infection has symptom rash on the face which spreads to the trunk and limbs, has symptom fever, has symptom lymphadenopathy, has symptom joint pains, has symptom headache, and has symptom conjunctivitis.

CDC:2 Rubella is a contagious disease caused by a virus. Most people who get rubella usually have a mild illness, with symptoms that can include a low-grade fever, sore throat, and a rash that starts on the face and spreads to the rest of the body. Rubella can cause a miscarriage or serious birth defects in an developing baby if a woman is infected while she is pregnant. The best protection against rubella is MMR (measles-mumps-rubella) vaccine.

Wikipedia:70 Rubella, also known as German measles or three-day measles, is an infection caused by the rubella virus.... more...

Related Diseases for Rubella

About this section

Diseases in the Rubella family:

Congenital Rubella

Diseases related to Rubella via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 283)
idRelated DiseaseScoreTop Affiliating Genes
1myelitis30.1CD40LG, MOG, TNF
2malignant histiocytosis29.3CD40LG, IL4, TNF
3asthma28.5CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL4, TNF
4congenital rubella12.5
5rubella panencephalitis11.9
6measles11.4
7mumps11.3
8cytomegalic inclusion disease11.1
9infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.8
10togaviridae disease10.8
11fruit allergy10.5HLA-DQB1, HLA-DRB1
12wolffian duct adenocarcinoma10.5HLA-DQB1, HLA-DRB1
13quinquaud's decalvans folliculitis10.5HLA-DQB1, HLA-DRB1
14pediatric systemic lupus erythematosus10.5HLA-DQB1, HLA-DRB1
15spondylarthropathy10.5HLA-DQB1, HLA-DRB1
16anthracosilicosis10.5HLA-DPB1, HLA-DRB1
17acute diffuse nephritis10.5CD40LG, HLA-B
18night blindness10.4CD40LG, TNF
19malignant cardiac germ cell tumor10.4HLA-A, HLA-DQB1
20rheumatic myocarditis10.4HLA-DQB1, HLA-DRB1
21brucella abortus brucellosis10.4CD40LG, TNF
22lens-induced iridocyclitis10.4CD40LG, HLA-DPB1
23weber syndrome10.4HLA-DRB1, TNF
24multifocal choroiditis10.4HLA-DRB1, MOG
25branch retinal artery occlusion10.4HLA-A, HLA-B
26newborn respiratory distress syndrome10.4HLA-DPB1, HLA-DRB1, MOG
27gonococcal iridocyclitis10.4HLA-A, HLA-B
28rhizomelic pseudopolyarthritis10.3HLA-DRB1, TNF
29nebulin-related early-onset distal myopathy10.3HLA-DQB1, HLA-DRB1
30aniseikonia10.3CD40LG, IL4
31vitreoretinochoroidopathy dominant10.3HLA-B, HLA-DQB1, HLA-DRB1
32abdominal chemodectomas with cutaneous angiolipomas10.3HLA-DRB1, TNF
336q terminal deletion syndrome10.3IL4, TNF
34granular cell tumor10.3CD40LG, IL4
35x-linked congenital generalized hypertrichosis10.3HLA-B, HLA-DQB1, HLA-DRB1
36myositis fibrosa10.3CD40LG, IL4
37bullous retinoschisis10.3HLA-DRB1, MOG, TNF
38krieble bixler syndrome10.3HLA-DQB1, HLA-DRB1, TNF
39fibrous histiocytoma10.3CD40LG, HLA-DRB1, TNF
40angiomyolipoma10.3CD40LG, MOG, TNF
41idiopathic central precocious puberty10.3HLA-DQB1, HLA-DRB1, TNF
42bile duct signet ring cell carcinoma10.3CD40LG, HLA-DRB1, TNF
43renovascular hypertension10.3CD40LG, HLA-DRB1, TNF
44basidiobolomycosis10.3IL4, TNF
45chronic apical periodontitis10.3CD40LG, HLA-DRB1, TNF
46paralytic lagophthalmos10.3IL4, TNF
47retroperitoneal fibrosis10.3CD40LG, HLA-DRB1, TNF
48caplan's syndrome10.3CD40LG, HLA-A, HLA-DPB1
49reproductive system disease10.3CD40LG, HLA-DRB1, TNF
50chronic intestinal vascular insufficiency10.2CD40LG, MOG, TNF

Graphical network of the top 20 diseases related to Rubella:



Diseases related to rubella

Symptoms for Rubella

About this section

Symptoms:

 11 (show all 6)
  • rash on the face which spreads to the trunk
  • fever
  • lymphadenopathy
  • joint pains
  • headache
  • conjunctivitis

UMLS symptoms related to Rubella:


exanthema, pruritus, rubella arthralgia

Drugs & Therapeutics for Rubella

About this section

Drugs for Rubella (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 35)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1VaccinesPhase 4, Phase 2, Phase 3, Phase 1, Early Phase 16428
2AntibodiesPhase 4, Phase 2, Phase 16045
3ImmunoglobulinsPhase 4, Phase 2, Phase 16045
4Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27793
5Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2454
6Liver ExtractsPhase 43868
7
Tetracyclineapproved, vet_approvedPhase 39960-54-85353990
Synonyms:
(-)-Tetracycline
(4S,4AS,5as,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
6-Methyl-1,11-dioxy-2-naphthacenecarboxamide
60-54-8
64-75-5 (mono-hydrochloride)
6591-49-7
87128_FLUKA
87128_SIGMA
AC-13151
AC1L1KAT
AC1NQXT7
AC1NRDAM
AC1NS4RQ
AC1NSDX8
AC1NTUT2
AC1NUZHL
AC1O52HS
Abramycin
Abricycline
Achromycin
Achromycin (naphthacene derivative)
Achromycin V
Achromycin, naphthacene derivative
Agromicina
Ambramicina
Ambramycin
Amycin
Anhydrotetracycline
BIDD:GT0653
BPBio1_000242
BSPBio_000220
BSPBio_001950
Bio-tetra
Biocycline
Bristaciclin
Bristaciclin .alpha.
Bristaciclina
Bristacycline
C06570
CHEBI:27902
CHEMBL1440
CID12309720
CID5280962
CID5289435
CID5353990
CID5359245
CID5388997
CID5412
CID5497101
CID6426717
Cefracycline
Cefracycline suspension
Centet (base)
Ciclibion
Copharlan
Criseociclina
Cyclomycin
Cyclopar
Cytome
D00201
DB00759
Democracin
Deschlorobiomycin
DivK1c_000827
Dumocyclin
EINECS 200-481-9
Enterocycline
HMS2090B04
HSDB 3188
Hostacyclin
IDI1_000827
KBio1_000827
KBio2_001514
KBio2_004082
KBio2_006650
KBio3_001450
KBioGR_000783
KBioSS_001514
LS-187078
LS-93869
Lemtrex (base)
Lexacycline
Limecycline
Liquamycin
Liquamycin (Veterinary)
 
Liquamycin, veterinary
MLS000069728
Medocycline
Mericycline
Micycline
MolPort-001-794-633
MolPort-003-983-460
MolPort-005-934-198
NCGC00161665-01
NINDS_000827
NSC 108579
NSC108579
Neocycline
Omegamycin
Orlycycline
Panmycin
Piracaps (base)
Polycycline
Polycycline (VAN)
Polycycline (antibiotic)
Polycycline, antibiotic
Polyotic
Prestwick0_000140
Prestwick1_000140
Prestwick2_000140
Prestwick3_000140
Purocyclina
Resteclin
Robitet
Roviciclina
SK-Tetracycline
SMR000058220
SPBio_001457
SPBio_002159
STOCK1N-42738
Sanclomycine
Solvocin
Spectrum2_001329
Spectrum3_000565
Spectrum4_000352
Spectrum5_001112
Spectrum_001034
Sumycin
Sumycin (TN)
Sumycin syrup
T-125
T3258_SIGMA
Tetra-Co
Tetrabon
Tetrachel
Tetraciclina
Tetraciclina [INN-Spanish]
Tetracycl
Tetracyclin
Tetracycline & VRC3375
Tetracycline (JAN/USP/INN)
Tetracycline (internal use)
Tetracycline Free Base
Tetracycline HCl
Tetracycline I
Tetracycline II
Tetracycline Monohydrochloride
Tetracycline [USAN:INN:BAN:JAN]
Tetracyclinum
Tetracyclinum [INN-Latin]
Tetracyn
Tetradecin
Tetrafil
Tetraverine
Tetrazyklin
Topicycline
Tsiklomistsin
Tsiklomitsin
Tétracycline
UNII-F8VB5M810T
UPCMLD-DP127
UPCMLD-DP127:001
UPCMLD-DP127:002
Veracin
Vetacyclinum
Vetquamycin-324 (free base)
WLN: L E6 C666 BV FV CU GUTTT&J DQ EQ GVZ HQ IN1&1 MQ M1 RQ
component of Tetrastatin
methyl-1,11-dioxo-2-naphthacenecarboxamide
nchembio.273-comp1
nchembio.289-comp1
tetracycline
8
Aluminum hydroxideapprovedPhase 3, Phase 220121645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
9
Vitamin Aapproved, nutraceutical, vet_approvedPhase 346811103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
10
LactitolPhase 3, Phase 2332585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
11PENTAPhase 3, Phase 2109
12Anti-Infective AgentsPhase 321402
13Anti-Bacterial AgentsPhase 310884
14Retinol palmitatePhase 3468
15VitaminsPhase 35095
16Trace ElementsPhase 35802
17MicronutrientsPhase 35802
18AntioxidantsPhase 32928
19Protective AgentsPhase 37190
20retinolNutraceuticalPhase 3468
21
AltretamineapprovedPhase 259645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
22AnticoagulantsPhase 22516
23Fibrinolytic AgentsPhase 22317
24Immunoglobulin GPhase 1265
25Immunoglobulin MPhase 19
26AutoantibodiesPhase 1126
27
Certolizumab pegolapproved122428863-50-7
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
 
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination)
Certolizumab pegol (genetical recombination) (JAN)
D03441
cimzia
28
Infliximabapproved378170277-31-3
Synonyms:
 
Ig gamma-1 chain C region
Remicade
29
Methotrexateapproved15181959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
30
Azathioprineapproved165446-86-62265
Synonyms:
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC-4230
AC1L1DAL
AC1Q3Z1F
AI-981/34845012
AI3-50290
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
Azathioprine (JP15/USP/INN)
Azathioprine Sodium
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57-322
BW 57322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
CHEBI:2948
CHEMBL1542
CID2265
CPD000427366
Ccucol
ChemDiv1_002659
Cytostatics
D00238
DB00993
DivK1c_000586
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
HMS1920E17
 
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imuran (tn)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
LS-123
Lopac-A-4638
Lopac0_000027
MLS001049307
Methylnitroimidazolylmercaptopurine
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC-39084
NSC39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
Prestwick_41
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
SPBio_000255
SPBio_001987
SPECTRUM1500133
STK831906
STOCK1S-20293
STOCK1S-27186
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
Spectrum_000064
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
[Methyl(nitroimidazolyl)mercaptopurine]
azathioprine
azatiopr in
cMAP_000046
31
Adalimumabapproved478331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
32Anti-HIV Agents3100
336-Mercaptopurine199
34Adjuvants, Immunologic2484
35AcidophilusNutraceutical518

Interventional clinical trials:

(show top 50)    (show all 124)
idNameStatusNCT IDPhase
1The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineUnknown statusNCT02153866Phase 4
2Coadministration of Measles-rubella and Rotavirus VaccinesCompletedNCT01700621Phase 4
3Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
4Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisCompletedNCT00731965Phase 4
5Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose PresentationsCompletedNCT01777529Phase 4
6Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
7Immunogenicity of Co-administration of Measles and Japanese Encephalitis VaccinesCompletedNCT02643433Phase 4
8Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819Phase 4
9MMR Vaccination Among HIV-infected AdultsCompletedNCT02724852Phase 4
10Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
11Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
12IPV Clinical Trial - The GambiaCompletedNCT01847872Phase 4
13MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
14Safety Study of a Refrigerator-Stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
15Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenCompletedNCT02253407Phase 4
16Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
17Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella VaccineRecruitingNCT02880865Phase 4
18Homeopathic Vaccine TrialRecruitingNCT02825368Phase 4
19Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 4
20Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRActive, not recruitingNCT02325310Phase 4
21Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
22Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy InfantsUnknown statusNCT01763268Phase 2, Phase 3
23Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
24Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
25Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderCompletedNCT02058563Phase 3
26Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3
27Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
28Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
29Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.CompletedNCT01991899Phase 3
30Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3
31Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
32Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
33Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
34Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3
35Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
36Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
37Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3
38ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
39ProQuad® rHA SafetyCompletedNCT00560755Phase 3
40Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
41Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3
42ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3
43Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered ConcomitantlyCompletedNCT00432042Phase 3
44Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
45Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
46Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety StudyCompletedNCT00326183Phase 3
47A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
48Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
49Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHACompletedNCT00566527Phase 3
50V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)CompletedNCT00109343Phase 3

Search NIH Clinical Center for Rubella


Cochrane evidence based reviews: rubella

Genetic Tests for Rubella

About this section

Anatomical Context for Rubella

About this section

MalaCards organs/tissues related to Rubella:

35
Skin, Eye, Brain, Heart, Testes, Lymph node, Liver

FMA organs/tissues related to Rubella:

17
Skin

Animal Models for Rubella or affiliated genes

About this section

Publications for Rubella

About this section

Articles related to Rubella:

(show top 50)    (show all 1243)
idTitleAuthorsYear
1
Rubella outbreak and outbreak management in a school setting, China, 2014. (27905834)
2016
2
Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010. (27196370)
2016
3
Rubella Immunity in Pregnant Native Taiwanese and Immigrants from Asian Countries. (27895276)
2016
4
An outbreak investigation of congenital rubella syndrome in Solomon Islands, 2013. (27757248)
2016
5
Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella-varicella vaccine in healthy Indian children from 9a88months of age: a phase III, randomised, non-inferiority trial. (26362659)
2015
6
Epidemiologic Surveillance on Measles, Rubella and Congenital Rubella Syndrome. Spain]. (26580792)
2015
7
Seroprevalence of measles, mumps and rubella among young adults, after 20A years of universal two-dose MMR vaccination in Israel. (25891446)
2015
8
Measles-Mumps-Rubella-Varicella Combination Vaccine (ProQuad(Ar)): A Guide to Its Use in Children in the EU. (25732634)
2015
9
Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy. (23574767)
2014
10
Evaluation of a novel array-based toxoplasma, rubella, cytomegalovirus, and herpes simplex virus IgG enzyme linked immunosorbent assay and its comparison with virion/serion enzyme linked immunosorbent assays. (24422194)
2014
11
Serological assessment of measles-rubella vaccination catch-up campaign among university students. (24417932)
2014
12
Congenital rubella syndrome: a review of laboratory data from 2002 to 2011. (24050074)
2013
13
Letter to the editor: commitment needed for the prevention of congenital rubella syndrome in Europe. (22433598)
2012
14
Congenital rubella syndrome and autism spectrum disorder prevented by rubella vaccination--United States, 2001-2010. (21592401)
2011
15
Sentinel phenotype for rubella embryopathy: time-space distribution in Brazil. (22031200)
2011
16
Anaphylactic reactions to measles-mumps-rubella vaccine in three children with allergies to hen's egg and cow's milk. (21244488)
2011
17
Surveillance and control of rubella in the republic of Korea from 2001 to 2009: the necessity for enhanced surveillance to monitor congenital rubella syndrome. (24159436)
2010
18
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. (20587679)
2010
19
Closer look at autism and the measles-mumps-rubella vaccine. (21071320)
2010
20
A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students. (20797454)
2010
21
Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma. (21708062)
2010
22
Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine. (19007835)
2009
23
Prevention of congenital rubella and congenital varicella in Europe. (19371507)
2009
24
Immunogenicity and safety of concomitant administration of a measles, mumps and rubella vaccine (M-M-RvaxPro) and a varicella vaccine (VARIVAX) by intramuscular or subcutaneous routes at separate injection sites: a randomised clinical trial. (19366435)
2009
25
Prevention of congenital rubella and congenital varicella in Europe. (19317971)
2009
26
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. (17564596)
2007
27
Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live). (17502347)
2007
28
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. (15655774)
2005
29
Congenital rubella syndrome due to infection after maternal antibody conversion with vaccine. (12824690)
2003
30
Incidence of congenital rubella syndrome at a hospital serving a predominantly Hispanic population, El Paso, Texas. (11230621)
2001
31
Prevention of congenital rubella syndrome. (20212977)
1999
32
Use of PCR for prenatal and postnatal diagnosis of congenital rubella. (8576339)
1995
33
Identification of calreticulin as a rubella virus RNA binding protein. (7809119)
1994
34
Congenital rubella syndrome. (8110709)
1994
35
Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays. (1572968)
1992
36
Increase in rubella and congenital rubella syndrome--United States, 1988-1990. (1899464)
1991
37
Gregg and congenital rubella: lessons from history and clinical research. (1789960)
1991
38
Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. (2470776)
1989
39
Congenital rubella syndrome in Malaysia. (3831727)
1985
40
Delayed manifestations of congenital rubella. (4001724)
1985
41
Congenital rubella syndrome in Nova Scotia. (4027829)
1985
42
The HLA system in congenital rubella patients with and without diabetes. (6959935)
1982
43
Congenital rubella syndrome: a continuing problem. (6799666)
1982
44
Keratoconus and acute hydrops in mentally retarded patients with congenital rubella syndrome. (7468739)
1981
45
Congenital rubella in an Indochinese refugee in Manitoba. (20313556)
1981
46
The devastating effects of congenital rubella. (106205)
1979
47
Behavioral consequences of congenital rubella. (702254)
1978
48
Nuclear and cytoplasmic immunofluorescence in the cerebrospinal fluid cells from a neonate with congenital rubella. (347227)
1977
49
Congenital rubella--an encapsulated review. (960007)
1976
50
The retinal disease of rubella. (6022716)
1967

Variations for Rubella

About this section

Expression for genes affiliated with Rubella

About this section
Search GEO for disease gene expression data for Rubella.

Pathways for genes affiliated with Rubella

About this section

Pathways related to Rubella according to GeneCards Suite gene sharing:

(show all 26)
idSuper pathwaysScoreTop Affiliating Genes
19.3CALR, HLA-A, HLA-B
29.1HLA-DPB1, HLA-DQB1, HLA-DRB1
39.1HLA-DPB1, HLA-DQB1, HLA-DRB1
4
Show member pathways
9.1HLA-DPB1, HLA-DQB1, HLA-DRB1
5
Show member pathways
9.0HLA-A, HLA-DRB1, IL4
68.9CD40LG, IL4, TNF
7
Show member pathways
8.9CD40LG, IL4, TNF
8
Show member pathways
8.9HLA-A, IFNAR2, TNF
98.7HLA-DRB1, IL4, TNF
108.7HLA-DRB1, IL4, TNF
118.6C1QBP, CD40LG, IL4, TNF
128.2HLA-DPB1, HLA-DQB1, HLA-DRB1, TNF
13
Show member pathways
8.0HLA-A, HLA-B, IFNAR2, IL4, TNF
14
Show member pathways
8.0HLA-A, HLA-B, IFNAR2, IL4, TNF
15
Show member pathways
7.9CD40LG, HLA-A, HLA-DPB1, HLA-DQB1, TNF
167.9CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
177.9CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
187.8HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, TNF
197.7HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB
20
Show member pathways
7.3HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNAR2
217.1CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
22
Show member pathways
7.1CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IL10RB, IL4
23
Show member pathways
6.8CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1, IFNAR2, IL10RB
24
Show member pathways
6.3CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1
25
Show member pathways
6.3C1QBP, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
26
Show member pathways
5.5CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

GO Terms for genes affiliated with Rubella

About this section

Cellular components related to Rubella according to GeneCards Suite gene sharing:

(show all 12)
idNameGO IDScoreTop Affiliating Genes
1MHC class I protein complexGO:004261210.3HLA-A, HLA-B
2MHC class II protein complexGO:00426139.7HLA-DPB1, HLA-DQB1, HLA-DRB1
3clathrin-coated endocytic vesicle membraneGO:00306699.7HLA-DPB1, HLA-DQB1, HLA-DRB1
4trans-Golgi network membraneGO:00325889.7HLA-DPB1, HLA-DQB1, HLA-DRB1
5transport vesicle membraneGO:00306589.6HLA-DPB1, HLA-DQB1, HLA-DRB1
6endocytic vesicle membraneGO:00306669.5HLA-DPB1, HLA-DQB1, HLA-DRB1
7external side of plasma membraneGO:00098979.0CALR, CD40LG, IL4, TNF
8ER to Golgi transport vesicle membraneGO:00125078.8HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
9integral component of lumenal side of endoplasmic reticulum membraneGO:00715568.6CALR, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
10Golgi membraneGO:00001398.6HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1
11cell surfaceGO:00099867.1C1QBP, CALR, CD40LG, HLA-A, HLA-B, HLA-DPB1
12plasma membraneGO:00058865.9C1QBP, CD40LG, HLA-A, HLA-B, HLA-DPB1, HLA-DQB1

Biological processes related to Rubella according to GeneCards Suite gene sharing:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of dendritic cell chemotaxisGO:200051010.5C1QBP, CALR
2antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independentGO:000248010.2HLA-A, HLA-B
3positive regulation of NIK/NF-kappaB signalingGO:190122410.0CALR, TNF
4regulation of immunoglobulin secretionGO:005102310.0CD40LG, TNF
5antigen processing and presentation of peptide antigen via MHC class IGO:000247410.0CALR, HLA-A, HLA-B
6type I interferon signaling pathwayGO:00603379.9HLA-A, HLA-B, IFNAR2
7positive regulation of mononuclear cell migrationGO:00716779.8IL4, TNF
8positive regulation of chemokine biosynthetic processGO:00450809.8IL4, TNF
9positive regulation of T cell proliferationGO:00421029.5CD40LG, HLA-DPB1, IL4
10response to virusGO:00096159.3IFNAR2, TNF, TRIM22
11regulation of immune responseGO:00507769.3CD40LG, HLA-A, HLA-B, IL4
12defense response to virusGO:00516079.2IFNAR2, IL10RB, TRIM22, TRIM5
13positive regulation of NF-kappaB transcription factor activityGO:00510929.2CD40LG, TNF, TRIM22, TRIM5
14antigen processing and presentation of exogenous peptide antigen via MHC class IIGO:00198869.0HLA-DPB1, HLA-DQB1, HLA-DRB1
15positive regulation of sequence-specific DNA binding transcription factor activityGO:00510918.9IL4, TNF, TRIM22, TRIM5
16T cell costimulationGO:00312958.8CD40LG, HLA-DPB1, HLA-DQB1, HLA-DRB1
17viral processGO:00160328.7C1QBP, HLA-A, HLA-B, TRIM22, TRIM5
18interferon-gamma-mediated signaling pathwayGO:00603338.1HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1, TRIM22
19immune responseGO:00069558.0C1QBP, HLA-DQB1, IL10RB, IL4, TRIM22

Molecular functions related to Rubella according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1complement component C1q bindingGO:00018499.6C1QBP, CALR
2peptide antigen bindingGO:00426058.2HLA-A, HLA-B, HLA-DPB1, HLA-DQB1, HLA-DRB1

Sources for Rubella

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet